UniProtKB/SwissProt variant VAR

Variant information

Variant position:

582

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Phenylalanine (F) at position 582 (V582F, p.Val582Phe).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (V) to large size and aromatic (F)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In AIS.

Any additional useful information about the variant.

Sequence information

Variant position:

582

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

920

The length of the canonical sequence.

Location on the sequence:

ICGDEASGCHYGALTCGSCK V FFKRAAEGKQKYLCASRNDC

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

                              ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Rhesus macaque                ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Chimpanzee                    ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Mouse                         ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Rat                           ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Pig                           ICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDC

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 920	Androgen receptor
DNA binding	560 – 632	Nuclear receptor
Region	1 – 587	Interaction with ZNF318
Region	552 – 919	Interaction with LPXN
Region	572 – 662	Interaction with HIPK3

Literature citations

A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome.
Lumbroso S.; Lobaccaro J.-M.; Belon C.; Martin D.; Chaussain J.-L.; Sultan C.;
Fertil. Steril. 60:814-819(1993)
Cited for: VARIANT AIS PHE-582;

Androgen receptor (AR) gene mutations in 6 families with androgen insensitivity syndrome (Abstract #114).
Lobaccaro J.-M.; Lumbroso S.; Belon C.; Chaussain J.L.; Toublanc J.E.; Leheup B.; Sultan C.;
Cited for: VARIANTS AIS PHE-582; VAL-744; VAL-755; GLU-768 AND CYS-856;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P10275: Variant p.Val582Phe